Copy number variants in pharmacogenetic genes.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Trends in Molecular Medicine

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molmed.2011.01.007PMID 21388883PMCID PMC3092840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The AmpliChip™ CYP450 Genotyping Test

  2012cited by this paper
• GSTT1 and GSTM1 gene polymorphisms in European and African populations

  2011cited by this paper
• Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

  2011cited by this paper
• Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus

  2010cited by this paper
• Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls

  2010cited by this paper
• Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma.

  2010cited by this paper
• Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended‐Duration Transdermal Nicotine Therapy

  2010cited by this paper
• Applying the genome to national drug formulary policy in the developing world.

  2010cited by this paper
• Influence of CYP2D6 Deletion, Multiplication, –1584C→G, 31G→A and 2988G→A Gene Polymorphisms on Dextromethorphan Metabolism among Mexican Tepehuanos and Mestizos

  2010cited by this paper
• Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

  2010cited by this paper
• CYP2D6 Polymorphisms as Predictors of Outcome in Breast Cancer Patients Treated with Tamoxifen: Expanded Polymorphism Coverage Improves Risk Stratification

  2010cited by this paper
• The Language of Life: DNA and the Revolution in Personalized Medicine

  2010cited by this paper
• Clinical practice. Early Alzheimer's disease.

  2010cited by this paper
• Endometrial Profile of Tamoxifen and Low-Dose Estradiol Combination Therapy

  2010cited by this paper
• GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.

  2010cited by this paper
• Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

  2009cited by this paper
• Codeine, ultrarapid-metabolism genotype, and postoperative death.

  2009cited by this paper
• CNVs of human genes and their implication in pharmacogenetics

  2009cited by this paper
• Genomewide association study of leprosy.

  2009cited by this paper
• Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance

  2009cited by this paper
• Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among Men of African Descent: A case-control study

  2009cited by this paper
• A multiplex real-time PCR method for detection of GSTM1 and GSTT1 copy numbers.

  2009cited by this paper
• Cytochrome P450 1A1, glutathione S-transferases M1 and T1 polymorphisms in Ovambos and Mongolians.

  2009cited by this paper
• CYP2D6 and tamoxifen: DNA matters in breast cancer

  2009cited by this paper
• Genetic polymorphisms of glutathione S-transferase and risk of vitiligo in the Chinese population.

  2009cited by this paper
• Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study

  2009cited by this paper
• Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia

  2009cited by this paper
• GSTM1 and GSTT1 deletion genotypes in various spontaneous optic neuropathies in Arabs

  2009cited by this paper
• The Affymetrix DMET platform and pharmacogenetics in drug development.

  2009cited by this paper
• The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction

  2009cited by this paper
• Pharmacogenomics of tamoxifen and aromatase inhibitors

  2008cited by this paper
• Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease.

  2008cited by this paper
• Genetic determinants of response to warfarin during initial anticoagulation.

  2008cited by this paper
• Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis.

  2008cited by this paper
• NO-donating tacrine hybrid compounds improve scopolamine-induced cognition impairment and show less hepatotoxicity.

  2008cited by this paper
• Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.

  2008cited by this paper
• Polymorphism of CYP1A1*2C, GSTM1*0, and GSTT1*0 in a Mexican Mestizo Population: A Similitude Analysis

  2008cited by this paper
• A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

  2008cited by this paper
• CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction

  2008cited by this paper
• The array CGH and its clinical applications.

  2008cited by this paper
• Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

  2008cited by this paper
• Pharmacogenomics of anti-TB drugs-related hepatotoxicity.

  2008cited by this paper
• Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine.

  2007cited by this paper
• Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication

  2007cited by this paper
• CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure

  2007cited by this paper
• Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population.

  2007cited by this paper
• CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?

  2007cited by this paper
• Determinants of the Variability of Aflatoxin–Albumin Adduct Levels in Ghanaians

  2006cited by this paper
• Global variation in copy number in the human genome

  2006cited by this paper
• Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

  2006cited by this paper
• Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review.

  2006cited by this paper
• Common deletion polymorphisms in the human genome

  2006cited by this paper
• AmpliChip CYP450 GeneChip®: A New Gene Chip That Allows Rapid and Accurate CYP2D6 Genotyping

  2006cited by this paper
• Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment

  2006cited by this paper
• Sequence-based CYP2D6 Genotyping in the Korean Population

  2006cited by this paper
• Pharmacogenomics and individualized drug therapy.

  2006cited by this paper
• CYP2D6*36 GENE ARRANGEMENTS WITHIN THE CYP2D6 LOCUS: ASSOCIATION OF CYP2D6*36 WITH POOR METABOLIZER STATUS

  2006cited by this paper
• Glutathione transferases.

  2005cited by this paper
• CYP2D6 genotype and phenotype determination in a Mexican Mestizo population

  2005cited by this paper
• Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH)

  2005cited by this paper
• Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

  2005cited by this paper
• Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: A prospective clinical study

  2005cited by this paper
• CYP2C8 polymorphism frequencies among malaria patients in Zanzibar

  2005cited by this paper
• Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen

  2004cited by this paper
• Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6

  2004cited by this paper
• GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma.

  2004cited by this paper
• Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol Pharmacokinetics and Pharmacodynamics

  2004cited by this paper
• Metabolic activity of dextromethorphan O-demethylation in healthy Japanese volunteers carrying duplicated CYP2D6 genes: duplicated allele of CYP2D6*10 does not increase CYP2D6 metabolic activity.

  2004cited by this paper
• Inheritance and drug response.

  2003cited by this paper
• The International HapMap Project

  2003cited by this paper
• CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real‐rime PCR

  2003cited by this paper
• Clinical practice. Early Alzheimer's disease.

  2003cited by this paper
• CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

  2002cited by this paper
• Unique CYP2D6 activity distribution and genotype‐phenotype discordance in black Americans

  2002cited by this paper
• Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis.

  2002cited by this paper
• Genetic polymorphisms of CYP2D6 in Chinese mainland.

  2002cited by this paper
• CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

  2002cited by this paper
• Metabolic gene polymorphism frequencies in control populations.

  2001cited by this paper
• Pharmacogenetics and adverse drug reactions.

  2000cited by this paper
• Combined glutathione‐S‐transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity

  2000cited by this paper
• CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10.

  2000cited by this paper
• Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.

  2000cited by this paper
• Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.

  2000cited by this paper
• Metoprolol: a review of its use in chronic heart failure.

  2000cited by this paper
• Metoprolol

  2000cited by this paper
• Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.

  1999cited by this paper
• Pharmacokinetics of nortriptyline and its 10‐hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes

  1998cited by this paper
• High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

  1998cited by this paper
• 10‐hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes

  1998cited by this paper
• Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

  1997cited by this paper
• Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians.

  1997cited by this paper
• Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.

  1996cited by this paper
• Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction.

  1996cited by this paper
• Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.

  1995cited by this paper
• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

  1992cited by this paper
• The Language Of Life

  1966cited by this paper

• Personalized Medicine and Pharmacogenomics: Impact of Genetic variation on Drug Response and Individualized Therapy - A Review

  2026cites this paper
• The Evolving Landscape of Pharmacogenomics: Current Achievements and Future Directions

  2026cites this paper
• Comparative Insights into NGS Platforms for Clinical Pharmacogenomics: Advantages, Limitations, and Workflow Strategies

  2025cites this paper
• Knowledge of the genetics of human pain gained over the last decade from next-generation sequencing.

  2025cites this paper
• Unveiling novel genetic variants in 370 challenging medically relevant genes using the long read sequencing data of 41 samples from 19 global populations

  2024cites this paper
• Ethnic and functional differentiation of copy number polymorphisms in Tunisian and HapMap population unveils insights on genome organizational plasticity

  2024cites this paper
• Integrated analysis of purine metabolism assists in predicting prognosis and treatment decisions for patients with lung adenocarcinoma

  2024cites this paper
• Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response

  2024cites this paper
• A crowdsourcing database for the copy-number variation of the Spanish population

  2023cites this paper
• Advances in pharmacogenomics for personalized emergency medicine

  2023cites this paper
• Implikasi Klinis Variasi Jumlah Copy Gen CYP2D6

  2023cites this paper
• Structural variation of the coding and non-coding human pharmacogenome

  2023cites this paper
• Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data

  2023cites this paper
• Integrating machine learning and single-cell trajectories to analyze T-cell exhaustion to predict prognosis and immunotherapy in colon cancer patients

  2023cites this paper
• DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation

  2023cites this paper
• Drug Response Prediction Based on 1D Convolutional Neural Network and Attention Mechanism

  2022cites this paper
• GSTM1 and GSTT1 polymorphisms in healthy volunteers – a worldwide systematic review

  2022cites this paper
• Cytochrome P450 Transcriptional Regulation by Testis‐Specific Y‐Encoded‐Like Protein: Identification of Novel Upstream Transcription Factors

  2022influential citation
• Simple and Robust Detection of CYP2D6 Gene Deletions and Duplications Using CYP2D8P as Reference

  2022cites this paper
• Characterizing the genetic polymorphisms in 370 challenging medically relevant genes using long-read sequencing data from 41 human individuals among 19 global populations

  2022cites this paper
• GPCR Patient Drug Interaction—Pharmacogenetics: Genome-Wide Association Studies (GWAS)

  2021cites this paper
• MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension

  2021cites this paper
• Extensive genome-wide duplications in the eastern oyster (Crassostrea virginica)

  2021cites this paper
• Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer

  2021cites this paper
• Genomewide Association Studies in Pharmacogenomics

  2021cites this paper
• Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

  2021cites this paper
• DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis

  2021cites this paper
• Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes

  2020cites this paper
• Copy number variation (CNV) as a promising genetic marker: distribution, validation methods and candidate genes in genomes of livestock species (review)

  2020cites this paper
• Clinical response to cholinesterase inhibitors in dementia

  2020cites this paper
• Вариация числа копий (CNV) как перспективный генетический маркер: распространение, методы валидации и гены-кандидаты в геномах сельскохозяйственных животных (обзор)

  2020cites this paper
• Genomic Copy Number Variation Study of Nine Macaca Species Provides New Insights into Their Genetic Divergence, Adaptation, and Biomedical Application

  2020cites this paper
• Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis

  2019cites this paper
• Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression

  2019cites this paper
• RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data

  2019cites this paper
• Basic Concepts in Genetics and Pharmacogenomics for Pharmacists

  2019cites this paper
• How many copies of GSTM1 and GSTT1 are associated with head and neck cancer risk?

  2019cites this paper
• Pharmacogenomics

  2019cites this paper
• Population Pharmacogenomics for Precision Public Health in Colombia

  2019cites this paper
• Genetic variants in CYP and GST genes, smoking and risk for head and neck cancers: a gene-environment interaction hospital-based case-control study among Canadian Caucasians.

  2019cites this paper
• Sequencing XMET genes to promote genotype-guided risk assessment and precision medicine

  2019cites this paper
• Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population

  2019cites this paper
• Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry

  2019cites this paper
• Human Mutation

  2019cites this paper
• Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population

  2019cites this paper
• Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data

  2019cites this paper
• Pharmacogenes (PGx-genes): Current understanding and future directions.

  2019cites this paper
• Beyond drugs: the evolution of genes involved in human response to medications

  2019cites this paper
• Population-haplotype models for mapping and tagging structural variation using whole genome sequencing

  2018cites this paper
• Genetic Contributions and Personalized Medicine

  2018cites this paper
• Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics

  2017cites this paper
• SULT1A1 copy number variation: ethnic distribution analysis in an Indian population

  2017cites this paper
• Methods to analyze big data in pharmacogenomics research.

  2017cites this paper
• Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays

  2017cites this paper
• Chapter 6 – Pharmacogenetics and Pharmacogenomics

  2017cites this paper
• Novel Tetra-Primer ARMS-PCR Assays for Thiopurine Intolerance Susceptibility Mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in East Asians

  2017cites this paper
• Standardized Care Versus Precision Medicine in the Perioperative Setting: Can Point-of-Care Testing Help Bridge the Gap?

  2017cites this paper
• Genetic variation in human drug-related genes

  2017cites this paper
• Role of GSTM1 Copy Number Variant in the Prognosis of Thai Colorectal Cancer Patients Treated with 5-FU-based Chemotherapy

  2016cites this paper
• Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms

  2016cites this paper
• Pharmacogenetics, the Promise of Translating Personalized Medicine into Clinical Pediatrics

  2016cites this paper
• The impact of the Cancer Genome Atlas on lung cancer.

  2015cites this paper
• Adaptive potential of genomic structural variation in human and mammalian evolution.

  2015cites this paper
• Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data

  2015cites this paper
• Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers

  2015cites this paper
• Exome sequence read depth methods for identifying copy number changes

  2015cites this paper
• Genomic structural variation in affective, anxiety, and stress-related disorders

  2014cites this paper
• Pharmacogenetics at 50: Genomic Personalization Comes of Age

  2014cites this paper
• Hidden Markov Model-Based CNV Detection Algorithms for Illumina Genotyping Microarrays

  2014cites this paper
• Application and interpretation of genome-wide association (GWA) studies for informing pharmacogenomic research - examples from the field of age-related macular degeneration.

  2014cites this paper
• Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.

  2014cites this paper
• Application of routine electronic health record databases for pharmacogenetic research

  2014cites this paper
• Predicting normal tissue toxicity in radiotherapy: can we improve clinical decision-making?

  2014cites this paper
• Génétique moléculaire des cancers : dualité hôte-tumeur

  2014cites this paper
• Droplet Digital Polymerase Chain Reaction: A Novel Method for Absolute Quantifi cation of the Target DNA

  2014cites this paper
• what, where, when, why, how and in which population?

  2014cites this paper
• Study of Genomic Copy Number Variation in Equine Health and Disease

  2014cites this paper
• TBHEB 2014-1 Vol 71 Full Printed Journal

  2014cites this paper
• Combining genetic variations in CYP2C9 and VKORC1 with clinical factors for warfarin dosing determination improved clinical effectiveness.

  2013cites this paper
• Cytochrome P450 and inflammation : pharmacogenomic approach and molecular aspects of anti-inflammatory effects of theinopyridines

  2013cites this paper
• Bringing genome-wide association findings into clinical use

  2013cites this paper
• Pharmacogenetics and Pharmacogenomics

  2013cites this paper
• Pharmacogenomics in Children: Advantages and Challenges of Next Generation Sequencing Applications

  2013cites this paper
• Analysis of copy number variations in the sheep genome using 50K SNP BeadChip array

  2013cites this paper
• Xenomic networks variability and adaptation traits in wood decaying fungi

  2013cites this paper
• A High-throughput Real-time PCR Approach to Pharmacogenomics Studies

  2013cites this paper
• Diversité fonctionelle des Glutation Transférases fongiques : caractérisation des classes Ure2p et GTT2 de Phanerochaete chrysosporium

  2013cites this paper
• Pharmacogenomics of Pulmonary and Respiratory Diseases

  2013cites this paper
• Research Highlights: Highlights from the latest research in cytochromes pharmacogenomics

  2013cites this paper
• Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies

  2013cites this paper
• CYP2A6, CYP2B6 and CYP2E1 copy number variation in five ethnic groups.

  2013cites this paper
• Ethnically diverse pluripotent stem cells for drug development.

  2012cites this paper
• Caractérisation structurale et enzymatique, cibles potentielles et rôles physiologiques de glutathion transférases à cystéine catalytique de Phanerochaete chrysosporium

  2012cites this paper
• An Introduction to Personalized Medicine

  2012cites this paper
• Introduction to Pharmacogenetics

  2012cites this paper
• Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU.

  2012cites this paper
• PharmGKB summary: very important pharmacogene information for GSTT1

  2012cites this paper
• Microscopic rearrangement of bound minor groove binders detected by NMR.

  2012cites this paper
• High-resolution melting analysis of 15 genes in 60 patients with cytochrome-c oxidase deficiency

  2012cites this paper
• Liver expression quantitative trait loci: a foundation for pharmacogenomic research

  2012cites this paper